MITCHEL SAYARE
CIK 1201196 · Chairman of the Board · last filed 2026-05-01
MITCHEL SAYARE is a Chairman of the Board who has filed 45 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for ALT, was dated May 1, 2026. Across all open-market trades the lifetime net is −$4.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $154.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$154.0K
3
45
-$4.29M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALT | Director | 59,013 | $2.61 | $154.0K | $10.0K | 13 | 2026-05-01 |
| Altimmune, Inc. (PIP) Delisted | Director | 217,139 | — | — | $10.8K | 11 | 2016-11-23 |
| ImmunoGen, Inc. (IMGN) Delisted | Director | 383,136 | $31.23 | $11.97M | -$4.31M | 21 | 2011-08-01 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-01 | ALT | Grant (A) | — | $0 | EDGAR |
| 2025-09-29 | ALT | Grant (A) | — | $0 | EDGAR |
| 2024-09-30 | ALT | Grant (A) | — | $0 | EDGAR |
| 2023-09-29 | ALT | Grant (A) | — | $0 | EDGAR |
| 2022-09-30 | ALT | Grant (A) | — | $0 | EDGAR |
| 2021-09-24 | ALT | Grant (A) | — | $0 | EDGAR |
| 2020-10-16 | ALT | Exer (M) | +25,275 | $0 | EDGAR |
| 2020-09-28 | ALT | Grant (A) | — | $0 | EDGAR |
| 2020-06-29 | ALT | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | ALT | Grant (A) | — | $0 | EDGAR |